Marcus Littman currently serves as Vice President of Drug Safety at Iovance Biotherapeutics, Inc., a position held since October 2019. Prior experience includes significant roles at Gilead Sciences as Senior Director and Associate Director from February 2008 to October 2019, and at Bristol-Myers Squibb as Associate Director from June 2003 to January 2008. Earlier career positions include Manager at Elan Pharmaceuticals and Safety Scientist at Parke-Davis. Marcus Littman holds an MBA in Finance and Operations Management from NYU Stern School of Business and a Bachelor of Science in Biology from the University of Michigan.
This person is not in the org chart
This person is not in any teams
This person is not in any offices